We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event

By LabMedica International staff writers
Posted on 16 Dec 2020
Print article
Image: Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event (Photo courtesy of Roche)
Image: Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event (Photo courtesy of Roche)
Roche (Basel, Switzerland) showcased leading-edge technology at its virtual booth at 2020 AACC Annual Scientific Meeting with demonstrations of the company’s newest additions to the cobas family of analyzers.

At the AACC Virtual 2020 Annual Scientific Meeting & Clinical Lab Expo, Roche demonstrated its new cobas pro integrated solution that allows laboratories to experience a new improved level of simplicity while achieving mid to high volume clinical chemistry and immunochemistry testing needs. Visitors to Roche’s virtual booth at AACC 2020 were able to see firsthand the newest innovations, including reduced maintenance, cobas AutoCal, and long on-board reagent stability. The cobas pro integrated solution includes the cobas ISE analytical unit that measures the concentration of sodium (Na+), potassium (K+) and chloride (Cl-), the all-new cobas c 503 analytical unit for clinical chemistry, and cobas e 801 analytical unit for immunochemistry. The state-of-the-art cobas pro offers a range of advanced features that help optimize workflow, improve productivity, and enhance reliability and turnaround times to support patient care.

Roche also gave viewers a peek behind the curtain to the innovations offered by cobas pure integrated solutions, the newest member of the cobas family of systems that is designed to deliver excellence, while at the same time simplifying daily work. Built on the latest technology, cobas pure integrated solutions combines clinical chemistry, immunoassay and ISE1 diagnostic testing on a footprint of just two square meters to achieve low to mid volume testing needs.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: Molecular PCR-grade detection of Lyme bacteria right at the tick bite (Photo courtesy of En Carta Diagnostics)

Groundbreaking Molecular Diagnostic Kit to Provide Lyme Disease Detection in Minutes

Lyme disease, transmitted through tick bites, is a bacteria-caused illness that impacts 1.2 million individuals annually. The standard methods for diagnosing this disease include clinical examinations,... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more